✦ LIBER ✦

Beta blocker/HCTZ combination is superior to beta blocker alone in black patients with mild to moderate hypertension.

✍ Scribed by I.V. Radevski; Z.P. Valtchanova; G.P. Candy; E. Tshele; P. Sareli

Book ID: 117605804
Publisher: Nature Publishing Group
Year: 1999
Tongue: English
Weight: 152 KB
Volume: 12
Category: Article
ISSN: 0895-7061
DOI: 10.1016/s0895-7061(99)80466-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of long-term treatment with nip

Efficacy of long-term treatment with nipradilol, a nitroester-containing beta-blocker, in patients with mild-to-moderate essential hypertension

✍ Takashi Haneda; Yuji Ogawa; Tadayuki Akaishi; Hiroki Takeda; Satoshi Tanazawa; H 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 655 KB

H54 Efficacy and safety of candesartan c

H54 Efficacy and safety of candesartan cilexetil in combination with hydrochlorothiazide (HCTZ) in the treatment of patients with mild to moderate hypertension unresponsive to HCTZ alone

✍ P.F. Plouin; E. Reti; S.G. Magin 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 142 KB

Calcium antagonists and beta blockers in

Calcium antagonists and beta blockers in the control of mild to moderate systemic hypertension, with particular reference to verapamil and propranolol

✍ Bramah N. Singh; Perlita Rebanal; Martha Piontek; Koonlawee Nademanee 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 882 KB

Quinapril/HCTZ combination rather than l

Quinapril/HCTZ combination rather than low-dose HCTZ should be recommended as first line antihypertensive therapy in black patients with mild to moderate hypertension.

✍ I.V. Radevski; Z.P. Valtchanova; G.P. Candy; M. Hopley; E. Tshele; P. Sareli 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 152 KB

Combination treatment with telmisartan a

Combination treatment with telmisartan and hydrochlorothiazide in black patients with mild to moderate hypertension

✍ Janet B. Mcgill; Paul A. Reilly 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 647 KB

Evaluation of celiprolol, a new cardiose

Evaluation of celiprolol, a new cardioselective beta1-adrenergic blocker with vasodilating properties, in the treatment of mild to moderate hypertension in the elderly

✍ K. D. Lamon 📂 Article 📅 1991 🏛 Springer US 🌐 English ⚖ 499 KB

Celiprolol hydrochloride is a cardioselective beta 1-adrenergic antagonist with partial agonist activity. The studies discussed were designed to assess celiprolol's pharmacokinetic disposition, its efficacy versus placebo and other beta blockers, its relative safety profile, and its therapeutic rati